المؤلفون: Fonseca, NM, Maurice-Dror, C, Herberts, C, Tu, W, Fan, W, Murtha, AJ, Kollmannsberger, C, Kwan, EM, Parekh, K, Schonlau, E, Bernales, CQ, Donnellan, G, Ng, SWS, Sumiyoshi, T, Vergidis, J, Noonan, K, Finch, DL, Zulfiqar, M, Miller, S, Parimi, S, Lavoie, JM, Hardy, E, Soleimani, M, Nappi, L, Eigl, BJ, Taavitsainen, S, Nykter, M, Tolmeijer, SH, Boerrigter, E, Mehra, N, van Erp, NP, De Laere, B, Lindberg, J, Gronberg, H, Khalaf, DJ, Annala, M, Chi, KN, Wyatt, AW

المصدر: Nature communications. 15(1):1828

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:155474166

المؤلفون: Slootbeek PHJ; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland., Tolmeijer SH; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland., Mehra N; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland., Schalken JA; Department of Experimental Urology, Research Institute of Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.

المصدر: Critical reviews in clinical laboratory sciences [Crit Rev Clin Lab Sci] 2024 May; Vol. 61 (3), pp. 178-204. Date of Electronic Publication: 2023 Oct 26.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8914816 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-781X (Electronic) Linking ISSN: 10408363 NLM ISO Abbreviation: Crit Rev Clin Lab Sci Subsets: In Process; MEDLINE

المؤلفون: Tolmeijer SH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., van Wilpe S; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Geerlings MJ; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., von Rhein D; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Smilde TJ; Department of Medical Oncology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands., Kloots ISH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Westdorp H; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Coskuntürk M; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, The Netherlands., van Ipenburg JA; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Hofste T; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Weiss MM; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Schalken JA; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Mehra N; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Niven.mehra@radboudumc.nl.

المصدر: European urology oncology [Eur Urol Oncol] 2024 Apr; Vol. 7 (2), pp. 282-291. Date of Electronic Publication: 2023 Sep 04.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Circulating Tumor DNA*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Prospective Studies ; Mutation

المؤلفون: Tolmeijer SH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Boerrigter E; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Sumiyoshi T; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Kwan EM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Ng SWS; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Annala M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland., Donnellan G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Herberts C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Benoist GE; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, the Netherlands., Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands., van Oort IM; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Schalken JA; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Mehra N; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., van Erp NP; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British of Columbia, Canada.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 01; Vol. 29 (15), pp. 2835-2844.

نوع المنشور: Research Support, Non-U.S. Gov't; Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/genetics , Prostatic Neoplasms, Castration-Resistant*/pathology , Circulating Tumor DNA*/genetics , Circulating Tumor DNA*/blood, Male ; Humans ; Prospective Studies ; Nitriles/therapeutic use ; Androgen Receptor Antagonists/therapeutic use

المؤلفون: Hofste LSM; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Geerlings MJ; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., von Rhein D; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Tolmeijer SH; Department of Medical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Weiss MM; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Gilissen C; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Hofste T; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Garms LM; Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Janssen MJR; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Rütten H; Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Rosman C; Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., van der Post RS; Department of Pathology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Klarenbeek BR; Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Pathology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

المصدر: Cancers [Cancers (Basel)] 2022 Sep 11; Vol. 14 (18). Date of Electronic Publication: 2022 Sep 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Tolmeijer SH; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Koornstra RHT; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Medical Oncology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands., de Groot JWB; Department of Medical Oncology, Isala Oncology Center, 8025 AB Zwolle, The Netherlands., Geerlings MJ; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., van Rens DH; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Mehra N; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

المصدر: Cancers [Cancers (Basel)] 2021 Aug 03; Vol. 13 (15). Date of Electronic Publication: 2021 Aug 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: van Wilpe S; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Tolmeijer SH; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Koornstra RHT; Department of Medical Oncology, Rijnstate Hospital, 6815 DA Arnhem, The Netherlands., de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Ligtenberg M; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Mehra N; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

المصدر: Cancers [Cancers (Basel)] 2021 May 07; Vol. 13 (9). Date of Electronic Publication: 2021 May 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Geerlings MJ; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Hofste LSM; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Kamping EJ; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Abdi Z; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Tolmeijer SH; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Garms LM; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Klarenbeek BR; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Ligtenberg MJL; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

المصدر: Clinical chemistry [Clin Chem] 2021 Jan 30; Vol. 67 (2), pp. 434-435.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9421549 Publication Model: Print Cited Medium: Internet ISSN: 1530-8561 (Electronic) Linking ISSN: 00099147 NLM ISO Abbreviation: Clin Chem Subsets: MEDLINE

مواضيع طبية MeSH: Blood Specimen Collection/*instrumentation , Cell-Free Nucleic Acids/*blood , Circulating Tumor DNA/*blood , Esophageal Neoplasms/*blood, Edetic Acid/chemistry ; Humans ; Limit of Detection

المؤلفون: Tolmeijer SH; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Boerrigter E; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Geerlings MJ; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Oort IM; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van Erp NP; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Mehra N; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

المصدر: JCO precision oncology [JCO Precis Oncol] 2020 Nov; Vol. 4, pp. 714-729.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Marijt KA; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands. K.A.Marijt@lumc.nl., Sluijter M; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands., Blijleven L; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands., Tolmeijer SH; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands., Scheeren FA; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands., van Hall T; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Jun 13; Vol. 7 (1), pp. 152. Date of Electronic Publication: 2019 Jun 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma, Experimental/*immunology , Melanoma, Experimental/*metabolism , Phosphatidylinositol 3-Kinases/*immunology , Phosphatidylinositol 3-Kinases/*metabolism , Receptors, Interferon/*antagonists & inhibitors, Animals ; Antigen Presentation ; Cell Hypoxia ; Cell Line, Tumor ; Glucose/deficiency ; Histocompatibility Antigens Class I/immunology ; Humans ; Interferon-gamma/immunology ; Interferon-gamma/metabolism ; Interferon-gamma/pharmacology ; Mice ; Mice, Inbred C57BL ; Phosphorylation ; Receptors, Interferon/immunology ; Receptors, Interferon/metabolism ; STAT1 Transcription Factor/immunology ; STAT1 Transcription Factor/metabolism ; Signal Transduction ; Stress, Physiological/immunology ; Tumor Escape ; Interferon gamma Receptor